Cardiovascular Impact of Diabetes Meds cover art

Cardiovascular Impact of Diabetes Meds

Cardiovascular Impact of Diabetes Meds

Listen for free

View show details

About this listen

Listen in as our expert panel discusses which diabetes meds have cardiovascular (CV) benefits. We’ll review the evidence and discuss the pros and cons of SGLT2 inhibitors (dapagliflozin, empagliflozin, etc) and GLP-1 agonists (dulaglutide, semaglutide, etc) in patients with or at risk for CV disease.

Special Guests:

  • Lauren G. Pamulapati, PharmD, BCACP
    • Associate Professor, Ambulatory Care
    • Virginia Commonwealth University School of Pharmacy
    • Clinical Pharmacist, Hayes Willis Health Center/VCU Health
  • Christie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP
    • Professor, Pharmacy Practice
    • Director, PGY2 Ambulatory Care Residency Program
    • Midwestern University College of Pharmacy, Downers Grove Campus
    • Clinical Pharmacist, Northwestern Medicine

TRC Editorial Advisory Board Participant:

  • Stephen Carek, MD, CAQSM, DipABLM
    • Clinical Associate Professor of Family Medicine
    • Prisma Health/USC-SOMG Family Medicine Residency Program
    • USC School of Medicine Greenville

For the purposes of disclosure, Dr. Schumacher reports a relevant financial relationship [CGM for diabetes management] with Abbott (speakers bureau).

The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.

This podcast is an excerpt from one of TRC’s monthly live CE webinars, the full webinar originally aired in February 2025.

TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist’s Letter, Pharmacy Technician’s Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.

Claim Credit

The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:

  • Chart: Diabetes Medications: Cardiovascular and Kidney Impact
  • Chart: Drugs for Type 2 Diabetes
  • Algorithm: Stepwise Treatment of Type 2 Diabetes
  • Chart: Comparison of GLP-1 Agonists
  • Toolbox: Improving Heart Failure Care

Send us a text


If you’re not yet a subscriber, find out more about our product offerings at trchealthcare.com.

Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.

You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

What listeners say about Cardiovascular Impact of Diabetes Meds

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.